Viral Hepatitis

You have full text access to this OnlineOpen article

Hepatitis C — identifying patients with progressive liver injury†

  1. Jordan J. Feld,
  2. T. Jake Liang*

Article first published online: 30 JAN 2006

DOI: 10.1002/hep.21065

Issue

Hepatology

Hepatology

Special Issue: 25th Anniversary Issue

Volume 43, Issue S1, pages S194–S206, February 2006

Additional Information

How to Cite

Feld, J. J. and Liang, T. J. (2006), Hepatitis C — identifying patients with progressive liver injury. Hepatology, 43: S194–S206. doi: 10.1002/hep.21065

Author Information

  1. Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD

*NIH, 10 CenterDrive, Room 9B16, Bethesda, MD, 20892

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 30 JAN 2006
  2. Article first published online: 30 JAN 2006

Funded by

  • Intramural Research Program of the NIH, National Institute of Diabetes and Digestive and Kidney Diseases

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (280K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Masao Omata, Tatsuo Kanda, Ming-Lung Yu, Osamu Yokosuka, Seng-Gee Lim, Wasim Jafri, Ryosuke Tateishi, Saeed S. Hamid, Wan-Long Chuang, Anuchit Chutaputti, Lai Wei, Jose Sollano, Shiv Kumar Sarin, Jia-Horng Kao, Geoffrey W. McCaughan, APASL consensus statements and management algorithms for hepatitis C virus infection, Hepatology International, 2012, 6, 2, 409

    CrossRef

  2. 2
    Carlo Fabris, Edmondo Falleti, Annarosa Cussigh, Davide Bitetto, Elisabetta Fontanini, Cosimo Colletta, Carmen Vandelli, Sara Cmet, Elisa Ceriani, Carlo Smirne, Pierluigi Toniutto, Mario Pirisi, The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases, Journal of Medical Virology, 2012, 84, 5
    Direct Link:
  3. 3
    Massimo Sartori, Silvano Andorno, Angelo Rossini, Renzo Boldorini, Cristina Bozzola, Stefania Carmagnola, Mario Del Piano, Emanuele Albano, A case–control histological study on the effects of phlebotomy in patients with chronic hepatitis C, European Journal of Gastroenterology & Hepatology, 2011, 23, 12, 1178

    CrossRef

  4. 4
    Carlo Fabris, Carmen Vandelli, Pierluigi Toniutto, Rosalba Minisini, Cosimo Colletta, Edmondo Falleti, Carlo Smirne, Mario Pirisi, Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases, Journal of Gastroenterology and Hepatology, 2011, 26, 2
    Direct Link:
  5. 5
    María Sara Sixtos-Alonso, Fausto Sánchez-Muñoz, Juan Francisco Sánchez-Ávila, Rosalba Avalos Martínez, Aaron Domínguez López, Florencia Vargas Vorácková, Misael Uribe, IFN-stimulated Gene Expression Is a Useful Potential Molecular Marker of Response to Antiviral Treatment with Peg-IFNα 2b and Ribavirin in Patients with Hepatitis C Virus Genotype 1, Archives of Medical Research, 2011, 42, 1, 28

    CrossRef

  6. 6
    Mohsan Saeed, Masaaki Shiina, Tomoko Date, Daisuke Akazawa, Noriyuki Watanabe, Asako Murayama, Tetsuro Suzuki, Haruo Watanabe, Nobuhiko Hiraga, Michio Imamura, Kazuaki Chayama, Youkyung Choi, Krzysztof Krawczynski, T. Jake Liang, Takaji Wakita, Takanobu Kato, In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis, Hepatology, 2011, 54, 2
    Direct Link:
  7. 7
    Zoe Raglow, Carly Thoma-Perry, Richard Gilroy, Yu-Jui Yvonne Wan, The interaction between HCV and nuclear receptor-mediated pathways, Pharmacology & Therapeutics, 2011, 132, 1, 30

    CrossRef

  8. 8
    Ana Mota, Fátima Guedes, Jorge Areias, Luciana Pinho, Margarida Fonseca Cardoso, Alcohol consumption among patients with hepatitis B infection in northern Portugal considering gender and hepatitis B virus genotype differences, Alcohol, 2010, 44, 2, 149

    CrossRef

  9. 9
    Edmondo Falleti, Carlo Fabris, Carmen Vandelli, Cosimo Colletta, Annarosa Cussigh, Carlo Smirne, Elisabetta Fontanini, Sara Cmet, Rosalba Minisini, Davide Bitetto, Pierluigi Toniutto, Mario Pirisi, Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C, Human Immunology, 2010, 71, 10, 999

    CrossRef

  10. 10
    Annarosa Cussigh, Edmondo Falleti, Carlo Fabris, Davide Bitetto, Sara Cmet, Elisabetta Fontanini, Sara Bignulin, Ezio Fornasiere, Elisa Fumolo, Rosalba Minisini, Mario Pirisi, Pierluigi Toniutto, Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C, Immunogenetics, 2010, 63, 1, 33

    CrossRef

  11. 11
    S. Gitto, L. Micco, F. Conti, P. Andreone, M. Bernardi, Alcohol and viral hepatitis: A mini-review, Digestive and Liver Disease, 2009, 41, 1, 67

    CrossRef

  12. 12
    Juliane Halangk, Thomas Berg, Konrad Neumann, Christoph Sarrazin, Holger Hinrichsen, Carolin Fitz, Gero Puhl, Tobias Mueller, Peter Neuhaus, Bertram Wiedenmann, Heiko Witt, Evaluation of Angiotensinogen c.1-44G>A and p.M268T Variants as Risk Factors for Fibrosis Progression in Chronic Hepatitis C and Liver Diseases of Various Etiologies, Genetic Testing and Molecular Biomarkers, 2009, 13, 3, 407

    CrossRef

  13. 13
    Michael G. Hughes, Hugo R. Rosen, Human liver transplantation as a model to study hepatitis C virus pathogenesis, Liver Transplantation, 2009, 15, 11
    Direct Link:
  14. 14
    Susanne Hagist, Holger Sültmann, Gunda Millonig, Ulrike Hebling, Dörthe Kieslich, Rupert Kuner, Sabrina Balaguer, Helmut-Karl Seitz, Annemarie Poustka, Sebastian Mueller, In vitro–targeted gene identification in patients with hepatitis C using a genome-wide microarray technology, Hepatology, 2009, 49, 2
    Direct Link:
  15. 15
    Jen-Eing Jeng, Huey-Ru Tsai, Lee-Yea Chuang, Jung-Fa Tsai, Zu-Yau Lin, Min-Yuh Hsieh, Shin-Chern Chen, Wan-Lung Chuang, Liang-Yen Wang, Ming-Lung Yu, Chia-Yen Dai, Jan-Gowth Chang, Independent and Additive Interactive Effects Among Tumor Necrosis Factor-α Polymorphisms, Substance Use Habits, and Chronic Hepatitis B and Hepatitis C Virus Infection on Risk for Hepatocellular Carcinoma, Medicine, 2009, 88, 6, 349

    CrossRef

  16. 16
    Carlo Fabris, Carlo Smirne, Stefano Fangazio, Pierluigi Toniutto, Michela Burlone, Rosalba Minisini, Davide Bitetto, Edmondo Falleti, Andrea Cerutti, Mario Pirisi, Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C, Hepatology Research, 2009, 39, 8
    Direct Link:
  17. 17
    Stephan L. Haas, Christel Weiß, Peter Bugert, Jutta Gundt, Heiko Witt, Manfred V. Singer, Thomas Berg, Ulrich Böcker, Interleukin 18 Promoter Variants (−137G>C and −607C>A) in Patients with Chronic Hepatitis C: Association with Treatment Response, Journal of Clinical Immunology, 2009, 29, 5, 620

    CrossRef

  18. 18
    Cristian Vallejos, Talya Bordin-Wosk, Lara Pockros, Anne Feng, Paul Pockros, Narcotic Analgesics and Progression of Fibrosis in Patients With Chronic Hepatitis C, Journal of Clinical Gastroenterology, 2009, 43, 4, 357

    CrossRef

  19. 19
    Sharif B. Missiha, Mario Ostrowski, E. Jenny Heathcote, Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors, Gastroenterology, 2008, 134, 6, 1699

    CrossRef

  20. 20
    Juliane Halangk, Christoph Sarrazin, Konrad Neumann, Gero Puhl, Tobias Mueller, Gerlinde Teuber, Hartwig Klinker, Holger Hinrichsen, Peter Buggisch, Olfert Landt, Viola Weich, Alexandra Bergk, Bertram Wiedenmann, Peter Neuhaus, Thomas Berg, Heiko Witt, Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection, Journal of Hepatology, 2008, 49, 3, 339

    CrossRef

  21. 21
    Evelyn K Hsu, Karen F Murray, Hepatitis B and C in children, Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5, 6, 311

    CrossRef

  22. 22
    Takanobu Kato, Youkyung Choi, Gamal Elmowalid, Ronda K. Sapp, Heidi Barth, Akihiro Furusaka, Shunji Mishiro, Takaji Wakita, Krzysztof Krawczynski, T. Jake Liang, Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation, Hepatology, 2008, 48, 3
    Direct Link:
  23. 23
    Matthew Hoare, William T. H. Gelson, Simon M. Rushbrook, Martin D. Curran, Tracy Woodall, Nicholas Coleman, Susan E. Davies, Graeme J. M. Alexander, Histological changes in HCV antibody–positive, HCV RNA–negative subjects suggest persistent virus infection, Hepatology, 2008, 48, 6
    Direct Link:
  24. 24
    Hermann E. Wasmuth, Mirko Moreno Zaldivar, Marie-Luise Berres, Alexa Werth, David Scholten, Sonja Hillebrandt, Frank Tacke, Petra Schmitz, Edgar Dahl, Tonio Wiederholt, Claus Hellerbrand, Thomas Berg, Ralf Weiskirchen, Christian Trautwein, Frank Lammert, The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection, Journal of Hepatology, 2008, 48, 2, 208

    CrossRef

  25. 25
    Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection, Journal of Gastroenterology and Hepatology, 2007, 22, 5
    Direct Link:
  26. 26
    Donna L Mendrick, Kellye K Daniels, From the bench to the clinic and back again: translational biomarker discovery usingin silicomining of pharmacogenomic data, Biomarkers in Medicine, 2007, 1, 2, 319

    CrossRef

  27. 27
    M.A. Serra, Historia natural de la infección por virus C, Gastroenterología y Hepatología, 2006, 29, 101

    CrossRef

  28. 28
    Armando Sánchez-Quijano, Eduardo Lissen-Otero, Tratamiento de las hepatitis víricas (II). Tratamiento de la hepatitis crónica C, Enfermedades Infecciosas y Microbiología Clínica, 2006, 24, 8, 518

    CrossRef

View Full Article (HTML) Get PDF (280K)